DE60139574D1 - Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung - Google Patents
Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutungInfo
- Publication number
- DE60139574D1 DE60139574D1 DE60139574T DE60139574T DE60139574D1 DE 60139574 D1 DE60139574 D1 DE 60139574D1 DE 60139574 T DE60139574 T DE 60139574T DE 60139574 T DE60139574 T DE 60139574T DE 60139574 D1 DE60139574 D1 DE 60139574D1
- Authority
- DE
- Germany
- Prior art keywords
- fibrinogen
- combination
- factor viia
- bleeding
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/000725 WO2002055102A1 (en) | 2001-01-10 | 2001-01-10 | Compositions for treatment of hemorrhaging with activated factor viia in combination with fibrinogen |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60139574D1 true DE60139574D1 (de) | 2009-09-24 |
Family
ID=21742239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60139574T Expired - Lifetime DE60139574D1 (de) | 2001-01-10 | 2001-01-10 | Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1351705B1 (de) |
AT (1) | ATE439142T1 (de) |
AU (1) | AU2001227771B2 (de) |
CA (1) | CA2437024A1 (de) |
DE (1) | DE60139574D1 (de) |
DK (1) | DK1351705T3 (de) |
ES (1) | ES2331461T3 (de) |
WO (1) | WO2002055102A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2894831B1 (fr) * | 2005-12-16 | 2008-02-15 | Lab Francais Du Fractionnement | Colle biologique exempte de thrombine et son utilisation comme medicament. |
FR3026644B1 (fr) * | 2014-10-07 | 2018-01-05 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Colle biologique et son utilisation comme medicament |
IL247821A0 (en) | 2016-09-14 | 2017-01-31 | Omrix Biopharmaceuticals Ltd | Adhesive preparations and their use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374617A (en) * | 1992-05-13 | 1994-12-20 | Oklahoma Medical Research Foundation | Treatment of bleeding with modified tissue factor in combination with FVIIa |
EP0885020A1 (de) * | 1996-02-20 | 1998-12-23 | Cohesion Corporation | Verbindungen zum gewebeverschluss und methoden zu deren gebrauch |
SI0796623T1 (en) * | 1996-03-20 | 2005-10-31 | Baxter Aktiengesellschaft | Pharmaceutical preparation for the treatment of blood coagulation disorders |
-
2001
- 2001-01-10 DE DE60139574T patent/DE60139574D1/de not_active Expired - Lifetime
- 2001-01-10 DK DK01901920T patent/DK1351705T3/da active
- 2001-01-10 CA CA002437024A patent/CA2437024A1/en not_active Abandoned
- 2001-01-10 EP EP01901920A patent/EP1351705B1/de not_active Expired - Lifetime
- 2001-01-10 WO PCT/US2001/000725 patent/WO2002055102A1/en active IP Right Grant
- 2001-01-10 ES ES01901920T patent/ES2331461T3/es not_active Expired - Lifetime
- 2001-01-10 AU AU2001227771A patent/AU2001227771B2/en not_active Ceased
- 2001-01-10 AT AT01901920T patent/ATE439142T1/de active
Also Published As
Publication number | Publication date |
---|---|
AU2001227771B2 (en) | 2007-05-31 |
EP1351705A1 (de) | 2003-10-15 |
CA2437024A1 (en) | 2002-07-18 |
WO2002055102A1 (en) | 2002-07-18 |
DK1351705T3 (da) | 2009-11-02 |
ES2331461T3 (es) | 2010-01-05 |
ATE439142T1 (de) | 2009-08-15 |
EP1351705B1 (de) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yi et al. | The use of pneumatic tourniquet in total knee arthroplasty: a meta-analysis | |
Sterling et al. | Hemostasis in burn surgery—a review | |
de Chalain | Exploring the use of the medicinal leech: a clinical risk-benefit analysis | |
Bilgili et al. | Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model | |
Toro et al. | TachoSil use in abdominal surgery: a review | |
ATE292979T1 (de) | Verwendung von aktiviertem protein-c zur behandlung überschiessender blutgerinnung bei sepsis | |
CY1113705T1 (el) | Μεθοδοι για τη θεραπεια αιμορραγικων διαταραχων με τη χρηση θειωμενων πολυσακχαριτων | |
MX2009001323A (es) | Aposito solido para tratar tejido herido. | |
ATE505488T1 (de) | Modulator von coagulationskaskaden und fibrinolytischen kaskaden | |
Jackson et al. | Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial | |
DE60139574D1 (de) | Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung | |
Petratos et al. | Transforming growth factor‐β2 (TGF‐β2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig | |
Velyvis | Gelatin matrix use reduces postoperative bleeding after total knee arthroplasty | |
Stevenson et al. | The superficial inferior epigastric artery flap for coverage of hand and forearm defects | |
DE69227042D1 (de) | Verfahren und zusammensetzungen zur verminderung von blutverlust | |
Irvine et al. | Hand venous hypertension complicating arterio‐venous fistula construction for haemodialysis | |
DE60040236D1 (de) | Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen | |
Rothwell et al. | ε-Amino caproic acid additive decreases fibrin bandage performance in a swine arterial bleeding model | |
Sussman et al. | Arteriovenous fistula for self-treatment of hemophilia | |
RU2381758C2 (ru) | Устройство для проведения ампутации конечности | |
Kuppusamy et al. | Hemostatic agents-A review. | |
Spotnitz | Tissue adhesives: science, products, and clinical use | |
TH76071A (th) | สารผสมสำหรับการบำบัดรักษาการตกเลือด ที่มีแฟกเตอร์ viia ที่ถูกกระตุ้นในการรวมกันด้วย ไฟบริโนเจน และวิธีการใช้สารนี้ | |
Reddy et al. | Forearm compartment syndrome following puncture of haemodialysis access fistula | |
Ghoz et al. | Suppl 2: M10: Use of a Thrombin Fibrin Sealant in Reducing Blood Loss in Revision Hip Arthroplasty |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |